Breast cancer and adjuvant endocrine therapy
Clinical research activity includes early breast cancer in post-menopausal patients with endocrine-responsive tumors, with attention to the integration of chemotherapy and aromatase inhibitors in the adjuvant setting.
- Endocrine-responsive breast cancer
- Adjuvant chemotherapy
- Aromatase inhibitors
- Disease recurrence prevention
Interest is centered on treatment strategies that support long-term control of hormone-sensitive disease.
Colorectal cancer survivorship
Research also covers stage IV colorectal cancer patients with no evidence of disease, focusing on post-treatment management in a setting of metastatic disease remission.
- No evidence of disease
- Stage IV colorectal cancer
- Disease-free survival
This area reflects continued clinical interest in outcomes after apparent disease clearance.
Cellular senescence and inflammatory biology
Another focus is the evaluation of cellular senescence and its associated inflammatory state, with interest in biomarkers linked to tissue aging and immune activation.
- Senescence markers
- Inflammatory status
- Healthy volunteers
This line of research connects translational medicine with mechanisms relevant to age-related and chronic disease processes.
